Chin‐Hsiao Tseng

12.9k total citations
241 papers, 9.6k citations indexed

About

Chin‐Hsiao Tseng is a scholar working on Endocrinology, Diabetes and Metabolism, Molecular Biology and Oncology. According to data from OpenAlex, Chin‐Hsiao Tseng has authored 241 papers receiving a total of 9.6k indexed citations (citations by other indexed papers that have themselves been cited), including 107 papers in Endocrinology, Diabetes and Metabolism, 106 papers in Molecular Biology and 47 papers in Oncology. Recurrent topics in Chin‐Hsiao Tseng's work include Metabolism, Diabetes, and Cancer (97 papers), Diabetes Treatment and Management (61 papers) and Diabetes, Cardiovascular Risks, and Lipoproteins (29 papers). Chin‐Hsiao Tseng is often cited by papers focused on Metabolism, Diabetes, and Cancer (97 papers), Diabetes Treatment and Management (61 papers) and Diabetes, Cardiovascular Risks, and Lipoproteins (29 papers). Chin‐Hsiao Tseng collaborates with scholars based in Taiwan, United States and South Sudan. Chin‐Hsiao Tseng's co-authors include Ching‐Ping Tseng, Hung‐Yi Chiou, Yu‐Mei Hsueh, Choon‐Khim Chong, Chien‐Jen Chen, Chom‐Kyu Chong, Chien‐Jen Chen, Tong‐Yuan Tai, Shou‐Hsia Cheng and Shyang‐Rong Shih and has published in prestigious journals such as PLoS ONE, The Journal of Clinical Endocrinology & Metabolism and Diabetes Care.

In The Last Decade

Chin‐Hsiao Tseng

238 papers receiving 9.3k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Chin‐Hsiao Tseng Taiwan 53 3.5k 2.6k 2.4k 2.1k 1.3k 241 9.6k
Jason G. Umans United States 50 1.4k 0.4× 874 0.3× 1.2k 0.5× 2.0k 1.0× 205 0.2× 304 9.7k
Duk‐Hee Lee South Korea 52 1.3k 0.4× 1.0k 0.4× 714 0.3× 5.4k 2.6× 322 0.2× 156 11.6k
Geoffrey R. Howe Canada 67 1.8k 0.5× 562 0.2× 720 0.3× 1.3k 0.6× 4.2k 3.1× 163 13.5k
Ta‐Chen Su Taiwan 54 837 0.2× 1.2k 0.4× 574 0.2× 2.4k 1.1× 397 0.3× 251 9.1k
Chien‐Jen Chen Taiwan 50 1.6k 0.5× 298 0.1× 1.9k 0.8× 1.8k 0.9× 1.4k 1.1× 138 9.3k
Adonina Tardón Spain 57 2.2k 0.6× 359 0.1× 544 0.2× 3.8k 1.8× 812 0.6× 252 9.9k
Lars Hagmar Sweden 61 2.0k 0.6× 1.3k 0.5× 606 0.3× 5.7k 2.8× 403 0.3× 188 11.8k
Mary L. Biggs United States 39 957 0.3× 745 0.3× 1.4k 0.6× 1.3k 0.6× 180 0.1× 101 5.1k
Elaine Hoffman United States 38 1.3k 0.4× 2.5k 1.0× 303 0.1× 742 0.4× 548 0.4× 64 10.6k
Sahoko Ichihara Japan 43 2.0k 0.6× 930 0.4× 290 0.1× 490 0.2× 340 0.3× 155 6.0k

Countries citing papers authored by Chin‐Hsiao Tseng

Since Specialization
Citations

This map shows the geographic impact of Chin‐Hsiao Tseng's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Chin‐Hsiao Tseng with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Chin‐Hsiao Tseng more than expected).

Fields of papers citing papers by Chin‐Hsiao Tseng

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Chin‐Hsiao Tseng. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Chin‐Hsiao Tseng. The network helps show where Chin‐Hsiao Tseng may publish in the future.

Co-authorship network of co-authors of Chin‐Hsiao Tseng

This figure shows the co-authorship network connecting the top 25 collaborators of Chin‐Hsiao Tseng. A scholar is included among the top collaborators of Chin‐Hsiao Tseng based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Chin‐Hsiao Tseng. Chin‐Hsiao Tseng is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Chen, Jung-Fu, Chin‐Hsiao Tseng, Yi-Jen Hung, et al.. (2020). Use and effectiveness of dapagliflozin in patients with type 2 diabetes mellitus: a multicenter retrospective study in Taiwan. PeerJ. 8. e9998–e9998. 6 indexed citations
2.
Tseng, Chin‐Hsiao. (2014). Diabetes but Not Insulin Increases the Risk of Lung Cancer: A Taiwanese Population-Based Study. PLoS ONE. 9(7). e101553–e101553. 34 indexed citations
3.
Tseng, Chin‐Hsiao. (2014). Pioglitazone does not affect the risk of kidney cancer in patients with type 2 diabetes. Metabolism. 63(8). 1049–1055. 10 indexed citations
4.
Tseng, Chin‐Hsiao. (2013). Human Insulin Does Not Increase Prostate Cancer Risk in Taiwanese. Clinical Genitourinary Cancer. 12(1). e7–e12. 7 indexed citations
5.
Cheng, Shou‐Hsia, Chi‐Chen Chen, & Chin‐Hsiao Tseng. (2013). Does medication adherence lead to lower healthcare expenses for patients with diabetes?. PubMed. 19(8). 662–70. 21 indexed citations
6.
Tseng, Chin‐Hsiao. (2012). Diabetes but not insulin is associated with higher colon cancer mortality. World Journal of Gastroenterology. 18(31). 4182–4182. 11 indexed citations
7.
Tseng, Chin‐Hsiao, et al.. (2012). Diabete and cancer: epidemiological, clinical and experimental perspectives (editorial). Experimental Diabetes Research. 1 indexed citations
8.
Mudhoo, Ackmez, Sanjeev Sharma, Vinod Kumar Garg, & Chin‐Hsiao Tseng. (2011). Arsenic: An Overview of Applications, Health, and Environmental Concerns and Removal Processes. Critical Reviews in Environmental Science and Technology. 41(5). 435–519. 155 indexed citations
9.
Tseng, Chin‐Hsiao. (2011). Prostate cancer mortality in Taiwanese men: Increasing age-standardized trend in general population and increased risk in diabetic men. Annals of Medicine. 43(2). 142–150. 31 indexed citations
10.
11.
12.
Tseng, Chin‐Hsiao, Choon‐Khim Chong, Ching‐Ping Tseng, et al.. (2007). Mortality, causes of death and associated risk factors in a cohort of diabetic patients after lower-extremity amputation: A 6.5-year follow-up study in Taiwan. Atherosclerosis. 197(1). 111–117. 32 indexed citations
13.
Chen, Chien‐Jen, Shu‐Li Wang, Jeng‐Min Chiou, et al.. (2007). Arsenic and diabetes and hypertension in human populations: A review. Toxicology and Applied Pharmacology. 222(3). 298–304. 129 indexed citations
14.
Tseng, Chin‐Hsiao, Ching‐Ping Tseng, Tzu‐Pi Huang, et al.. (2006). Increasing incidence of diagnosed type 2 diabetes in Taiwan: analysis of data from a national cohort. Diabetologia. 49(8). 1755–1760. 101 indexed citations
15.
16.
Tseng, Chin‐Hsiao, Chin‐Hsiao Tseng, Ching‐Ping Tseng, et al.. (2002). Epidemiologic evidence of diabetogenic effect of arsenic. Toxicology Letters. 133(1). 69–76. 139 indexed citations
17.
Tseng, Chin‐Hsiao, Chin‐Hsiao Tseng, Choon‐Khim Chong, et al.. (2002). Long-term arsenic exposure and ischemic heart disease in arseniasis-hyperendemic villages in Taiwan. Toxicology Letters. 137(1-2). 15–21. 189 indexed citations
18.
Wang, Shu‐Li, Jeng‐Min Chiou, Chien‐Jen Chen, et al.. (2002). Prevalence of non-insulin-dependent diabetes mellitus and related vascular diseases in southwestern arseniasis-endemic and nonendemic areas in Taiwan.. Environmental Health Perspectives. 111(2). 155–159. 111 indexed citations
19.
Tseng, Ching‐Ping, Ann‐Joy Cheng, Joseph Tung‐Chieh Chang, et al.. (2002). Quantitative Analysis of Multidrug‐resistance mdr1 Gene Expression in Head and Neck Cancer by Real‐time RT‐PCR. Japanese Journal of Cancer Research. 93(11). 1230–1236. 9 indexed citations
20.
Lin, Mei‐Hui, Chin‐Hsiao Tseng, Chin‐Hsiao Tseng, et al.. (2001). Real-time PCR for rapid genotyping of angiotensin-converting enzyme insertion/deletion polymorphism. Clinical Biochemistry. 34(8). 661–666. 39 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Jason G. Umans Breakdown of academic impact, for papers by Duk‐Hee Lee Breakdown of academic impact, for papers by Geoffrey R. Howe Breakdown of academic impact, for papers by Ta‐Chen Su Breakdown of academic impact, for papers by Chien‐Jen Chen Breakdown of academic impact, for papers by Adonina Tardón Breakdown of academic impact, for papers by Lars Hagmar Breakdown of academic impact, for papers by Mary L. Biggs Breakdown of academic impact, for papers by Elaine Hoffman Breakdown of academic impact, for papers by Sahoko Ichihara
Rankless by CCL
2026